OPEN END TURBO OPTIONSSCHEIN SHORT - BRISTOL-MYERS SQUIBB | Market Closed - BOERSE MUENCHEN 02:26:52 2024-06-24 pm EDT | ||
| 2.745 EUR | -2.76% |
|
| 1 month | +5.30% | ||
| 3 months | +49.60% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-24 | 2.745 | -2.76% |
| 24-06-21 | 2.823 | -2.08% |
| 24-06-20 | 2.883 | +0.80% |
| 24-06-19 | 2.86 | -0.66% |
| 24-06-18 | 2.879 | +0.42% |
Real-time BOERSE MUENCHEN
Last update June 24, 2024 at 02:26 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Goldman Sachs |
| WKN | GQ4QW5 |
| ISIN | DE000GQ4QW57 |
| Date issued | 2023-09-11 |
| Strike | 71.73 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.14 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.928 € |
|---|---|
| Lowest since issue | 1.14 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.23
USD
Average target price
53.19
USD
Spread / Average Target
+25.96%
- Stock Market
- Certificates
- Certificat
